Učitavanje...
How I treat hepatitis C virus infection in patients with hematologic malignancies
Hepatitis C virus (HCV) infection is not uncommon in cancer patients. Over the past 5 years, treatment of chronic HCV infection in patients with hematologic malignancies has evolved rapidly as safe and effective direct-acting antivirals (DAAs) have become the standard-of-care treatment. Today, chron...
Spremljeno u:
| Izdano u: | Blood |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6033045/ https://ncbi.nlm.nih.gov/pubmed/27443290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-05-718643 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|